Cart
sales@molnova.com
Glycolithocholic acid
CAS No. 474-74-8
Glycolithocholic acid( Lithocholylglycine | Lithocholic acid glycine conjugate )
Catalog No. M27986 CAS No. 474-74-8
Glycolithocholic acid is a glycine conjugate of lithocholic acid.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 80 | In Stock |
|
| 5MG | 72 | In Stock |
|
| 10MG | 126 | In Stock |
|
| 25MG | 269 | In Stock |
|
| 50MG | 423 | In Stock |
|
| 100MG | 625 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGlycolithocholic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionGlycolithocholic acid is a glycine conjugate of lithocholic acid.
-
DescriptionGlycolithocholic acid is a glycine conjugate of lithocholic acid.
-
In Vitro——
-
In Vivo——
-
SynonymsLithocholylglycine | Lithocholic acid glycine conjugate
-
PathwayOthers
-
TargetOther Targets
-
RecptorCarbonic anhydrase I|Carbonic anhydrase II|Carbonic anhydrase IX|CAXII
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number474-74-8
-
Formula Weight433.633
-
Molecular FormulaC26H43NO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (115.31 mM)
-
SMILES[H][C@@]12CC[C@H]([C@H](C)CCC(=O)NCC(O)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@H](O)CC[C@]12C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Gieling et al (2012) Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts. J.Med.Chem. 55 5591
molnova catalog
related products
-
EZH2-IN-15
EZH2-IN-15 (SHR2554) is a specific inhibitor of the zeste 2 histone modification enhancer (EZH2).EZH2 is aberrantly overexpressed in many human cancers and controls adaptive responses by regulating Treg activity.
-
Ataquimast
Ataquimast is used in curing advanced receptor-positive breast cancer.
-
Moschamine
Moschamine is a very potent compound that is able to inhibit COX-I by 58% and COX-II by 54%, at the concentration of 0.1 μmol L⁻1, it may suppress cAMP formation via binding to 5-HT1 receptors in the cells. Moschamine exerts antitumour effects on HeLa, MCF7 and A431 cells.
